+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Preparedness for ebolavirus disease outbreak in Japan: Necessity of Biosafety level-4 facility



Preparedness for ebolavirus disease outbreak in Japan: Necessity of Biosafety level-4 facility



Uirusu 65(1): 89-94



Although a globe box-type highly contained laboratory with the internationally-recognized biosafety level-4 standards has been constructed in the Murayama Annex, the National Institute of Infectious Diseases, Tokyo, Japan (NIID) in 1981, the laboratory has never been operated as BSL-4 laboratory since its construction. Furthermore, there are no other BSL-4 laboratories in operation in Japan. The evidence indicates that infectious BSL-4 pathogens such as Ebola and Marburg viruses cannot be manipulated in Japan, making it impossible to study the BSL-4 pathogens using the infectious viruses. A large-scale outbreak of ebolavirus disease (EVD) has occurred in the western Africa such as Guinea, Sierra Leone, and Liberia. Furthermore, the highly pathogenic pathogens' infectious diseases outbreaks such as SARS, Nipah encephalitis, Middle East respiratory syndrome (MERS) have emerged in the world. However, BSL-4 laboratories are not present in Japan, making it difficult to study these pathogens and infectious diseases. Because these emerging virus infections are caused by the zoonotic pathogens, the eradiation and the elimination of these infectious diseases are impossible. We need to develop the diagnostics, therapeutics, and preventive measures based on the studies of the highly pathogenic pathogens more in detail using the infectious microbes. Therefore, BSL-4 in operation in Japan is required to minimize the risk of and combat these emerging highly pathogenic pathogens' infectious diseases.

(PDF emailed within 0-6 h: $19.90)

Accession: 058609337

Download citation: RISBibTeXText

PMID: 26923962

DOI: 10.2222/jsv.65.89


Related references

External quality assessment study for ebolavirus PCR-diagnostic promotes international preparedness during the 2014 - 2016 Ebola outbreak in West Africa. Plos Neglected Tropical Diseases 11(5): E0005570, 2017

NIH opens top level biosafety facility. Nature Medicine 4(2): 136, 1998

Current problems arising from not having biosafety level 4 laboratories in Japan--qualitative study of infectious disease experts. Nihon Eiseigaku Zasshi. Japanese Journal of Hygiene 64(4): 806-810, 2011

Development of a head-out plethysmograph system for non-human primates in an Animal Biosafety Level 3 facility. Journal of Pharmacological and Toxicological Methods 55(1): 96-102, 2006

Certification & validation of biosafety level-2 & biosafety level-3 laboratories in Indian settings & common issues. Indian Journal of Medical Research 146(4): 459-467, 2018

The European network of Biosafety-Level-4 laboratories: enhancing European preparedness for new health threats. Clinical Microbiology and Infection 15(8): 720-726, 2009

Establishment of Biosafety Level-3 (BSL-3) laboratory: important criteria to consider while designing, constructing, commissioning & operating the facility in Indian setting. Indian Journal of Medical Research 140(2): 171-183, 2015

Epidemiology of ebolavirus disease (EVD) and occupational EVD in health care workers in Sub-Saharan Africa: Need for strengthened public health preparedness. Journal of Epidemiology 27(10): 455-461, 2017

Contingency plans IV: Preparedness: Everyone at your facility must have training at some level, whether basic or advanced. Chemical Health and Safety 6(6): 8-11, 1999

Comparison of respiratory inductive plethysmography versus head-out plethysmography for anesthetized nonhuman primates in an animal biosafety level 4 facility. Inhalation Toxicology 28(14): 670-676, 2016

Preventing the emergence of Ebola disease in unaffected countries: necessity of preparedness. International Journal of Health Policy and Management 3(7): 417-418, 2014

Hepatitis E virus outbreak in monkey facility, Japan. Emerging Infectious Diseases 18(12): 2032-2034, 2013

Evaluating the efficacy of hydrogen peroxide vapour against foot-and-mouth disease virus within a BSL4 biosafety facility. Letters in Applied Microbiology 65(4): 281-284, 2017

Biosafety and biosecurity measures: management of biosafety level 3 facilities. International Journal of Antimicrobial Agents 36 Suppl 1: S70-S74, 2011

The measles outbreak in Chikuhou district, Fukuoka, Japan, 1990: Correlation between herd immunity level and outbreak size. Acta Paediatrica Japonica 34(4): 447-453, 1992